or Try an Advanced Search...

    Technical Analysis for RNA - Avidity Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 43.65 0.92% 0.40
    RNA closed up 0.92 percent on Wednesday, November 20, 2024, on 51 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical RNA trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Centerline Cross Bearish 0.92%
    Slingshot Bearish Bearish Swing Setup 0.92%
    Bullish Engulfing Bullish 0.92%
    Stochastic Reached Oversold Weakness 0.92%
    Gapped Down Weakness 0.92%
    Oversold Stochastic Weakness 0.92%
    MACD Bearish Signal Line Cross Bearish 5.56%
    Hammer Candlestick Bullish 5.56%
    Older End-of-Day Signals for RNA ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 21 hours ago
    Up 2% about 22 hours ago
    60 Minute Opening Range Breakout about 23 hours ago
    Up 1% about 23 hours ago
    Rose Above Previous Day's High about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RNA Chart by TradingView
    Basic chart:

    Profile

    Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products

    Is RNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
    Nov 14 RNA Stock Hits Record High on Entering the Cardiac Disease Space
    Nov 13 Avidity Bio Has Surged 416% This Year — And That's Before Today's 'Game-Changing' News
    Nov 13 Avidity Biosciences jumps 16%; reaches all-time high
    Nov 12 Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations
    Nov 9 Avidity Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 8 Avidity Biosciences reports Q3 results
    Nov 7 Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Lags Revenue Estimates
    Nov 7 Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
    Nov 6 Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for
    See more RNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 56.0
    52 Week Low 5.97
    Average Volume 1,331,226
    200-Day Moving Average 34.85
    50-Day Moving Average 45.39
    20-Day Moving Average 45.30
    10-Day Moving Average 46.10
    Average True Range 3.20
    RSI (14) 45.95
    ADX 12.04
    +DI 28.27
    -DI 28.72
    Chandelier Exit (Long, 3 ATRs) 46.39
    Chandelier Exit (Short, 3 ATRs) 49.11
    Upper Bollinger Bands 50.75
    Lower Bollinger Band 39.86
    Percent B (%b) 0.35
    BandWidth 24.04
    MACD Line -0.31
    MACD Signal Line 0.13
    MACD Histogram -0.4359
    Fundamentals Value
    Market Cap 3.47 Billion
    Num Shares 79.4 Million
    EPS -3.00
    Price-to-Earnings (P/E) Ratio -14.55
    Price-to-Sales 113.02
    Price-to-Book 2.05
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 47.30
    Resistance 3 (R3) 47.23 45.93 46.69
    Resistance 2 (R2) 45.93 45.00 45.97 46.49
    Resistance 1 (R1) 44.79 44.43 45.36 44.87 46.29
    Pivot Point 43.50 43.50 43.78 43.54 43.50
    Support 1 (S1) 42.36 42.57 42.93 42.43 41.01
    Support 2 (S2) 41.06 41.99 41.10 40.81
    Support 3 (S3) 39.92 41.06 40.61
    Support 4 (S4) 40.00